|
Apr 14
|
Soleno Therapeutics Announces VYKAT(TM) XR Launch
|
|
Apr 1
|
High Growth Tech Stocks To Watch In The US April 2025
|
|
Mar 30
|
Why Soleno Therapeutics Inc. (SLNO) Went Up Last Week?
|
|
Mar 29
|
Why Soleno Therapeutics Inc. (SLNO) Went Up On Friday?
|
|
Mar 28
|
Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday?
|
|
Mar 27
|
Soleno Surges Into Breakout On Hard-Won Obesity-Tied Approval, But Aardvark Reverses Lower
|
|
Mar 27
|
Tiny Drugmaker Soars on FDA Win to Treat Never-Ending Hunger
|
|
Mar 27
|
Soleno wins FDA approval for Prader-Willi hyperphagia treatment
|
|
Mar 27
|
Soleno stock skyrockets on FDA drug approval
|
|
Mar 27
|
SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug
|
|
Mar 26
|
Soleno Therapeutics Announces U.S. FDA Approval of VYKATTM XR to Treat Hyperphagia in Prader-Willi Syndrome
|
|
Mar 3
|
Exploring US High Growth Tech Stocks In March 2025
|
|
Feb 27
|
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
|
|
Oct 9
|
SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA
|
|
Oct 8
|
Why Soleno Therapeutics Stock Blasted 9% Higher Today
|
|
Oct 8
|
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome
|
|
Oct 3
|
Janus Henderson Group PLC's Strategic Acquisition in Soleno Therapeutics Inc
|
|
Oct 2
|
High Growth Tech Stocks To Watch In The United States
|
|
Sep 16
|
Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference
|
|
Aug 28
|
Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review
|